UBS Maintains Buy on Labcorp Holdings, Raises Price Target to $420
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice Target
UBS analyst Kevin Caliendo maintains Labcorp Holdings (NYSE:LH) with a Buy and raises the price target from $380 to $420.
UBS analyst Kevin Caliendo maintains Labcorp Holdings (NYSE:LH) with a Buy and raises the price target from $380 to $420.